WT1 peptide vaccine is known to induce clinical responses in MDS, AML, CML, ALL, multiple myeloma and various types of solid tumors including lung and breast cancers (Oka et al., 2004; Oka et al., 2017). Here, WT1 is linked to breast cancer.